Warner Wellcome consumer ad campaign for Zantac 75 in U.K. begins Feb. 27.
This article was originally published in The Tan Sheet
Executive Summary
WARNER WELLCOME CONSUMER AD CAMPAIGN FOR ZANTAC 75 IN U.K. is scheduled to begin Feb. 27 with a national print campaign. The campaign will be followed by national television and "women's press" advertising throughout the year, according to the company. Warner Wellcome highlighted the phrase, "helps put you in control," in Jan. 25 press materials describing ad plans for the British launch of its nonprescription Zantac (ranitidine) 75 mg for dyspepsia.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: